Abstract: The present invention relates to compounds defined by Formula (I), wherein the groups A, B, X, m, n and o are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

Abstract: An organic electroluminescent light source has at least one substrate and layers that are arranged on the substrate. The layers include electrodes of which at least one electrode is transparent and one acts as an anode and one as a cathode, and at least one organic electroluminescent layer that is arranged between the electrodes. The organic electroluminescent layer has regions that emit blue light and/or green light, and at least one phosphor layer that is arranged in the beam path of the light leaving the organic electroluminescent light source and that partly covers the electroluminescent layer.

Abstract: The present invention relates to compounds defined by formula I wherein the groups R1 to R3, X, m, n and o are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

Abstract: The present invention relates to compounds defined by formula I wherein the variables R1, R2, R3, R4, and m are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of 11?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.

Abstract: The present invention relates to compounds defined by formula (I) wherein the groups A, B, X, m, n and o are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11 ?-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity and dyslipidemia.

Abstract: The invention relates to a light emitting diode arrangement comprising a first light emitting diode (101), in particular an organic light emitting diode, comprising a first light emitting layer (105) and a first electrode (109) arranged on the first light emitting layer (105), and a second light emitting diode (103), in particular an organic light emitting diode, being arranged upon the first light emitting diode (101), the second light emitting diode (103) comprising a second light emitting layer (113) and a second electrode (117) arranged on the second light emitting layer (113), the second electrode (117) being translucent.

Abstract: The invention relates to a double sided light emitting diode device (1) comprising a transparent substrate layer (2) with a layer system, featuring at least a first emitting layer (3) and at least a second emitting layer (4).

Abstract: The invention relates to the substituted 1,2-ethylenediamines of general formula (I), wherein the groups R1 to R13, A, B, L and i are defined as in the description and the claims. The invention also relates to the use thereof in the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: A composite frame (110) for insertion in a building aperture comprises a blind frame (112) and a sash frame (114) hinged to the blind frame (112), wherein the sash frame (114) has an inner sash frame profile (116) and on an outward facing side of the inner sash frame profile (116) is provided an adapter profile (118) fixedly connected to the inner sash frame profile (116) for fixedly inserting a panel (120) provided for this purpose. The blind frame (112) comprises an inner blind frame profile (122) essentially surrounding the inner sash frame profile (116) and on a side of the inner blind frame profile (122) on the outside of the building is provided an outer visible part (124) fixedly connected to the inner blind frame profile (122).

Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Abstract: A bipolar plate which can be produced particularly economically for a fuel cell, with which a high degree of efficiency is guaranteed over a long service life. The bipolar plate has a core layer consisting of a steel material, the surfaces of said core layer, which are associated with the respective electrolyte carriers of the fuel cell, having a corrosion protection layer, protecting the core layer against corrosion. The corrosion protection layers consist of a metal material and extend on both sides over the whole surface of the core layer. At the same time the corrosion protection layers are in turn coated over the whole surface with an electrically conductive functional coating, which is essentially entirely impermeable for the metal ions emerging from the core layer and/or the corrosion protection layers. The invention likewise relates to at least one fuel cell comprising a bipolar plate according to the invention.

Abstract: The present invention relates to a light emitting device (30) having at least a first (10) and a second light emitting element (20), with the first light emitting element (10) emitting a first light (1) and the second light emitting element (20) emitting a second light (2), each light emitting element (10,20) being an OLED (10,20), the OLED (10,20) comprising a sandwich structure with a substrate (14,24), a first (11,21) and a second electrode (12,22) and an organic layer (13,23) being provided between the first (11,21) and the second electrode (12,22), a light (3) leaving the light emitting device (30), wherein at least a part of said light (3) is provided by a superposition of the first (1) and the second light (2).

Abstract: The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and in the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

Abstract: The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1—X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: The invention relates to a light emitting system (1) for surfaces (2) of floor bottoms, walls or similar surfaces (2) of buildings for indoor or outdoor applications, in particular walkable or drivable surfaces (2), whereas the system comprises a laminar and plane base floor material (3) for flooring the surface (2), featuring a top surface (4) characterised in that on said top surface (4) of said base floor material (3) is layered a light guiding structure (5) for propagating light, which is coupled into said structure (5), whereas said structure (5) features an emission surface (6), arranged coplanar to the top surface (4) of said base floor material (3) for emitting the light.

Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: A tunable radiation emitting semiconductor device includes at least one elongated structure at least partially fabricated from one or more semiconductor materials exhibiting a bandgap characteristic including one or more energy transitions whose energies correspond to photon energies of light radiation. The structure is operable to emit light radiation in response to a current flow therethrough. Moreover, the elongated structure is fabricated to be sufficiently narrow for quantum confinement of charge carriers associated with the current flow to occur therein. Furthermore, the structure further includes an electrode arrangement for applying an electric field to the elongated structure for causing bending of its bandgap characteristic for modulating a wavelength of the light radiation emitted in operation from the structure in response to the current flow therethrough.

Abstract: The present invention relates to a device for simultaneous simulation of a symmetrical and an asymmetrical impedance of an asynchronous machine. The device has three subcircuits for simulating the three phases of the asynchronous machine. Each subcircuit preferably comprises a series connection of a main inductance, a leakage inductance and a resistor between the input terminal and the output terminal, which are connected in parallel to ground across a capacitor and a resistor in each case. A magnetic coupling is implemented or the effect of a magnetic coupling is simulated for the main inductances of the subcircuits. This device can be used to advantage instead of the asynchronous machine in calibration of EMC filters.